Napp Pharmaceuticals Limited - Strategic SWOT Analysis Review

Date: May 10, 2016
Pages: 18
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NA249994CE9EN

Download PDF Leaflet

Napp Pharmaceuticals Limited - Strategic SWOT Analysis Review
Napp Pharmaceuticals Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

  • Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.

Napp Pharmaceuticals Limited (Napp Pharmaceuticals), a subsidiary of Napp Pharmaceutical Holdings Limited, develops and manufactures pharmaceutical products. The company offers pharmaceutical products for the treatment of chronic pain, cancer, respiratory diseases and inflammatory disorders. It also provides products for the treatment of blood cancers, pain management and cardiovascular conditions. Napp Pharmaceuticals’ products are manufactured and marketed through Bard Pharmaceuticals Limited. The company works with Association of the British Pharmaceutical Industry (ABPI) for its clinical research and patient care. It has operations in Europe, North America, Asia, Australia, Africa and joint ventures in Cyprus, India and Israel. Napp Pharmaceuticals is headquartered in Cambridge, the UK.

Napp Pharmaceuticals Limited Key Recent Developments

Sep 11, 2015: NICE draft guidance recommends treatments for types of arthritis that affect the spine
Sep 02, 2015: NICE issues draft guidance recommending drugs for rheumatoid arthritis

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Napp Pharmaceuticals Limited - Key Facts
Napp Pharmaceuticals Limited - Key Employees
Napp Pharmaceuticals Limited - Major Products and Services
Napp Pharmaceuticals Limited - History
Napp Pharmaceuticals Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture


Napp Pharmaceuticals Limited - Business Description
Napp Pharmaceuticals Limited - Corporate Strategy
Napp Pharmaceuticals Limited - SWOT Analysis
SWOT Analysis - Overview
Napp Pharmaceuticals Limited - Strengths
Strength - Focused Research and Development Efforts
Strength - Strong Partnership
Napp Pharmaceuticals Limited - Weaknesses
Weakness - Lack of Pipeline Products
Napp Pharmaceuticals Limited - Opportunities
Opportunity - Growth Prospects: Oncology Market
Opportunity - Market Potential: Pain Management Drugs
Opportunity - New product launch
Napp Pharmaceuticals Limited - Threats
Threat - Stringent Government Regulations
Threat - Competitive Landscape
Threat - Uncertain R&D Outcomes
Napp Pharmaceuticals Limited - Key Competitors


Sep 11, 2015: NICE draft guidance recommends treatments for types of arthritis that affect the spine
Sep 02, 2015: NICE issues draft guidance recommending drugs for rheumatoid arthritis


About GlobalData
Contact Us


Napp Pharmaceuticals Limited, Key Facts
Napp Pharmaceuticals Limited, Key Employees
Napp Pharmaceuticals Limited, Major Products and Services
Napp Pharmaceuticals Limited, History
Napp Pharmaceuticals Limited, Subsidiaries
Napp Pharmaceuticals Limited, Joint Venture
Napp Pharmaceuticals Limited, Key Competitors
Skip to top

Ask Your Question

Napp Pharmaceuticals Limited - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: